| Simplified criteria for the diagnosis of autoimmune hepatitis EM Hennes, M Zeniya, AJ Czaja, A Parés, GN Dalekos, EL Krawitt, ... Hepatology 48 (1), 169-176, 2008 | 2304 | 2008 |
| Incidence of inflammatory bowel disease across Europe: is there a difference between north and south Results of the European collaborative study on inflammatory bowel disase … Gut 39, 690-697, 1996 | 1605 | 1996 |
| A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis HSA Newsome PN, Buchholtz K, Cusi K, Linder M, Okanoue T, Ratziu V, Sanyal ... New England Journal of Medicine 384 (12), 1113-1124, 2021 | 1496 | 2021 |
| EASL clinical practice guidelines: autoimmune hepatitis European Association for the Study of The Liver Journal of hepatology 63 (4), 971-1004, 2015 | 1061 | 2015 |
| EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study KK Ray, B Molemans, WM Schoonen, P Giovas, S Bray, G Kiru, J Murphy, ... European journal of preventive cardiology 28 (11), 1279-1289, 2021 | 712 | 2021 |
| Peginterferon plus adefovir versus either drug alone for hepatitis delta H Wedemeyer, C Yurdaydìn, GN Dalekos, A Erhardt, Y Çakaloğlu, ... New England Journal of Medicine 364 (4), 322-331, 2011 | 561 | 2011 |
| Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis TJ Weismüller, PJ Trivedi, A Bergquist, M Imam, H Lenzen, CY Ponsioen, ... Gastroenterology 152 (8), 1975-1984. e8, 2017 | 526 | 2017 |
| Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial E Kyriazopoulou, G Poulakou, H Milionis, S Metallidis, G Adamis, ... Nature medicine 27 (10), 1752-1760, 2021 | 521 | 2021 |
| PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy G Papatheodoridis, G Dalekos, V Sypsa, C Yurdaydin, M Buti, J Goulis, ... Journal of hepatology 64 (4), 800-806, 2016 | 513 | 2016 |
| Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis JZ Liu, JR Hov, T Folseraas, E Ellinghaus, SM Rushbrook, NT Doncheva, ... Nature genetics 45 (6), 670-675, 2013 | 456 | 2013 |
| Late HDV RNA relapse after peginterferon alpha‐based therapy of chronic hepatitis delta B Heidrich, C Yurdaydın, G Kabacam, BA Ratsch, K Zachou, B Bremer, ... Hepatology 60 (1), 87-97, 2014 | 334 | 2014 |
| The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B GV Papatheodoridis, R Idilman, GN Dalekos, M Buti, H Chi, ... Hepatology 66 (5), 1444-1453, 2017 | 325 | 2017 |
| Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience HL Tillmann, J Hadem, L Leifeld, K Zachou, A Canbay, C Eisenbach, ... Journal of viral hepatitis 13 (4), 256-263, 2006 | 320 | 2006 |
| Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics NK Gatselis, K Zachou, GK Koukoulis, GN Dalekos World journal of gastroenterology: WJG 21 (1), 60, 2015 | 286 | 2015 |
| aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis R Fan, G Papatheodoridis, J Sun, H Innes, H Toyoda, Q Xie, S Mo, ... Journal of hepatology 73 (6), 1368-1378, 2020 | 278 | 2020 |
| COVID-19 mortality risk assessment: An international multi-center study PA Bertsimas D, Lukin G, Mingardi L, Nohadani O, Orfanoudaki A, Stellato B ... PLoS 15 (12), e0243262, 2020 | 245* | 2020 |
| autoimmune hepatitis–current management and challenges K Zachou, P Muratori, GK Koukoulis, A Granito, N Gatselis, A Fabbri, ... Alimentary pharmacology & therapeutics 38 (8), 887-913, 2013 | 238 | 2013 |
| Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of … K Zachou, N Gatselis, G Papadamou, EI Rigopoulou, GN Dalekos Journal of hepatology 55 (3), 636-646, 2011 | 226 | 2011 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 222 | 2022 |
| Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease K Zachou, E Rigopoulou, GN Dalekos Journal of autoimmune diseases 1, 1-17, 2004 | 218 | 2004 |
